Professional Documents
Culture Documents
Barat Biotech PDF
Barat Biotech PDF
l-
tffi\
I
-4'->'
t\rgrl I
lcm?
ffi \67
i]."1flt[??!E1,"3[
This is to bring to your kind attention that ICMR has partnered with Bharat Biotech lnternational Limited
(BBIL) to fast-track clinical trials of the indiSenous CoVID-19 vaccine (BBV152 COVID Vaccine).
This is the first indigenous vaccine being developed by lndia and is one of the top Priority prolects which
is being monitored at the topmost level of the Government. The vaccine is derived from a strain of SARS-
CoV-z isolated by tCMR-National lnstitute of Virology, Pune. ICMR and BBIL are jointly working for the
preclinical as well as clinical development of this vaccine.
It is envisaged to launch the vaccine for public health use latest by 15thAugust2020 after completion of all
clinical trials. BBIL is working expeditiously to meet the target, however finaloutcome will depend on the
cooperation of all clinical trial sites involved in this pro.iect.
you have been chosen as a clinical trial site of the BBV152 COVID vaccine. ln view of the public health
emergency due to COVID-19 pandemic and urgency to launch the vaccine, you are strictly advised to fast
track all approvals related to initiation of the clinical trial and ensure that the subiect enrollment is
initiated no later than 7th July 2020.
Kindly note that non-compliance will be viewed very seriously. Therefore, you are advised to treat this
project on highest priority and meet the given timelines without any lapse.
With regards
Yours sincerely
Copy to:
:!
ga r x-7 :?r!-= x-= L/ o =B -l
t1
t 7o 6
s.=
P-I o) ai @'- -; I
(D'id
=>'e ,9A !- iBEiI
^c
o;: 5 rlo e q)
_:
o ro i'')
*qt *Fl
oi o- *.
a-=2-
;'d =9
<'==- s^ a'a (!
I= /J 2-]I, J Z
IP
=-
nio=
ar.) D) ts"f ; =y
=c) =
E)
o
aD O-1^ T a7 t:-
oo- oe -)p o =.o ='
AF = l< =
oa
o
, I=
-rax
tdo
I
e< ^ lo)
t=
o kro Y. -' l!e
I 'Et
o- lPgo < I
I
^i- I lF)
lo l0
I
I
I
lrD
6le. E
lrr
t=
l(D
{r,l
t- t? tE Itz t=:
t..t= a li ,II,, la-
la l; {a lE
l3 E' to- 0'.
la) lo-
lo- l:. (o = lc (F)
la lii lo t:.
l- Ua
li. t:- E 3 lb a t3
l.) l=' l= k le.
lq l- lo IJ t-
ls) t lr- l3 li)
i' lo
lo to- lo- l5
lo
l= l:r
la)
ta
lrD
tf lo-
l!0 llo. IC'
l= la')
k IT ls
=
lo)
0a
ts l--
q1
E (e) ha
l=' l!J
to
IL {R)
to
Ua l= t-
l*J
l-_ l.!. h._
l= Ur
t! ti* L-r 1l li! t?.
(s) ls t- lP.
L; lo- q9 Itr lh t-
lo lq {o t= lo A
lo) E l!D
lo
It lb lF) lb
l3
lo l= b.
c)<zioO(, 3aT9 aaF alvl
o O:r -)Oao
EiFJ g;C (,
r" =r=o .D \of ==
TE xE'
6
o o a-
I ?2 z1
: _ai
(IO
(n E -, O)
9>H =
+ -:iD=
!! =oa -*. ci > EZa zt
O:5B
3\-)' 6
=0aE \<poPI= PL<B ES o 6'
o) O ' 0) iii a-r\ <l o a
u,:i
--'\
.j *P.L' 'z1 =_
ooi -/\=
Y.p d o
'- -!. ,j, 'i- fi s_9
0a s
g{ : K = -9 ro
!D
ii99 i" 6-
rc) a\o t-.i 0a
+< iS 'on
o- '- ;r H.E ^., = :E
o
f(J
a+
'-
t c,a7 .Y
; =\, 2:
!.
et
D)
lto
c
?i;
' t-)
F
(D a
oal dJ
F) X -, =oq
E t, Pa= P-'-. ==.>
E + tlJ
c =an I
I:68
p o
E
a V-
oE >
'n :1 x P- ()
--1 na= tu <=> i =.4
99
o9.P 2>V = o;
ia
q9. tA'--
^-= 0a gqc P i!;m Ig a=c)
a= 6i! < _2. x ,EI
36 :'+
=
L5 P o=v cs <%
3
B
i-= Ery nZ+o
o(J 7 oo Pc,;-
3
'o ga iu: a oq
e:- jr
6
oa R'2 its
qs' 6'
5 r'a
t+
m